Posts
January 25 2017
Fintech Acquisition Corp. II announced the closing of their initial public offering in the amount of $153,000,000. EG&S acted as counsel to Cantor Fitzgerald.
January 24 2017
Amedica Corporation announced the closing of their Confidentially Marketed Public Offering in the amount of $4,500,000. EG&S acted as counsel to Maxim Group.
January 24 2017
EGS assisted PhotoMedex, Inc. in its sale of substantially all of its assets primarily related to or used in the company’s consumer products division, including its no!no!® hair and skin products and the Kyrobak back pain management products.
The gross proceeds receivable by the company were up to $5M. In addition, the company entered into a royalty agreement with the purchaser.
January 24 2017
Can-Fite Biopharma Ltd. announced the closing of their Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
January 23 2017
EnteroMedics, Inc. announced the closing of their Underwritten offering in the amount of $20,125,009. EG&S acted as counsel to the Underwriter.
January 23 2017
PURE Bioscience, Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
January 20 2017
Uranium Energy Corp. announced the closing of their Underwritten offering in the amount of $25,996,254. EG&S acted as counsel to the Underwriter.
January 11 2017
Sequel Youth and Family Services and Global Partner Acquisition Corp. announce agreement for business combination. EG&S acted as special SPAC counsel to Global Partner Acquisition.